Asano Y, Hirose S, Iwayama S, Miyata T, Yazaki T, Takahashi M
Biken J. 1982 Mar;25(1):43-5.
The protective effect on 45 household contacts of immediate inoculation of a live varicella vaccine was examined in relation to the viral dose and days after exposure to varicella. The viral doses used were 300 PFU to 15,000 PFU, and the intervals between exposure and vaccination were 0 to 5 days. All 30 contacts given viral doses of 800 to 15,000 PFU within 3 days after exposure were protected from clinical varicella. With lower viral doses of 300 to 600 PFU within 3 days after exposure, 6 to 10 contacts developed rashes 13 to 25 days after vaccination, but all showed mild symptoms. When vaccine was given 5 days after exposure, even with a dose of 1,500 to 4,000 PFU, typical varicella symptoms appeared 6 to 9 days after vaccination. These results suggest that vaccination of household contacts with viral doses of over 500-800 PFU within 3 days after exposure is effective in preventing manifestation of clinical varicella and that clinical symptoms may be modified to a mild form by vaccination with even a lower viral dose when given within 3 days after exposure.
针对45名家庭接触者,研究了在接触水痘后立即接种活水痘疫苗的保护效果,该效果与病毒剂量以及接触水痘后的天数有关。所用病毒剂量为300 PFU至15,000 PFU,接触与接种疫苗之间的间隔为0至5天。所有在接触后3天内接受800至15,000 PFU病毒剂量的30名接触者均免受临床水痘感染。在接触后3天内接受较低病毒剂量300至600 PFU的情况下,6至10名接触者在接种疫苗后13至25天出现皮疹,但所有症状均较轻。当在接触后5天接种疫苗时,即使剂量为1,500至4,000 PFU,接种疫苗后6至9天也会出现典型的水痘症状。这些结果表明,接触后3天内对家庭接触者接种超过500 - 800 PFU病毒剂量的疫苗可有效预防临床水痘的表现,并且在接触后3天内接种即使较低病毒剂量的疫苗也可将临床症状减轻为轻度形式。